Universität zu Köln

Al-Sawaf, Othman ORCID: 0000-0001-9895-0570, Seymour, John F., Kater, Arnon P. and Fischer, Kirsten (2021). Should Undetectable Minimal Residual Disease Be the Goal of Chronic Lymphocytic Leukemia Therapy? Hematol. Oncol. Clin. North Am., 35 (4). S. 775 - 792. PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC. ISSN 1558-1977

Full text not available from this repository.

Abstract

Hospital, German CLL Study Group, Gleueler Strasse 176, 50935 Cologne, Germany; b Department of Hematology, Peter MacCallum Cancer Centre, Royal Melbourne Hospital, University of Melbourne, 305 Grattan Street, Melbourne, Victoria 3000, Australia; cDepartment of Hematology, Cancer Center Amsterdam, Lymphoma and Myeloma Research Center Amsterdam (LYMMCARE), Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands * Corresponding author. Department of Hematology, D3-221.1, Amsterdam University Medical Centers, Location AMC, Meibergdreef 9, Amsterdam 1105AZ, the Netherlands.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Al-Sawaf, Othman UNSPECIFIED orcid.org/0000-0001-9895-0570 UNSPECIFIED Seymour, John F. UNSPECIFIED UNSPECIFIED UNSPECIFIED Kater, Arnon P. UNSPECIFIED UNSPECIFIED UNSPECIFIED Fischer, Kirsten UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-591195
DOI:	10.1016/j.hoc.2021.03.007
Journal or Publication Title:	Hematol. Oncol. Clin. North Am.
Volume:	35
Number:	4
Page Range:	S. 775 - 792
Date:	2021
Publisher:	W B SAUNDERS CO-ELSEVIER INC
Place of Publication:	PHILADELPHIA
ISSN:	1558-1977
Language:	English
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language PREVIOUSLY UNTREATED PATIENTS; OPEN-LABEL; FOLLOW-UP; 1ST-LINE TREATMENT; FLOW-CYTOMETRY; INDEPENDENT PREDICTOR; CELL TRANSPLANTATION; PLUS CHLORAMBUCIL; CLL; RITUXIMAB Multiple languages Oncology; Hematology Multiple languages
URI:	http://kups.ub.uni-koeln.de/id/eprint/59119